SWK Holdings Corp., a Diversified Financials company based in the United States of America, has an ESG risk rating score of 26.3, indicating a medium risk assessment. Specializing in healthcare capital provision, SWK Holdings Corp offers financial solutions to various life science entities, institutions, and innovators. Their services involve monetizing cash flows from commercial-stage products and intellectual property through royalty purchases and financings, as well as creating synthetic revenue interests in commercialized products. With operating segments in Finance Receivables and Pharmaceutical Development Services, the company primarily generates revenue from the Finance Receivables segment.